Scarica l'app Stockscreener
78.80
0.05%
0.04
Dopo l'orario di chiusura:
78.75
-0.05
-0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$78.76
Aprire:
$78.77
Volume 24 ore:
1.09M
Relative Volume:
0.52
Capitalizzazione di mercato:
$38.71B
Reddito:
$10.19B
Utile/perdita netta:
$1.05B
Rapporto P/E:
37.45
EPS:
2.1044
Flusso di cassa netto:
$1.38B
1 W Prestazione:
-2.39%
1M Prestazione:
-0.81%
6M Prestazione:
-11.58%
1 anno Prestazione:
-8.09%
Intervallo 1D:
$78.25
$79.30
Intervallo di 1 settimana:
$78.25
$80.44
Portata 52W:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ALC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update) - MSN
Aug Decliners: Will Alcon Inc 2U3 stock outperform global peersQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal - MSN
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid - Investing.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Australia
Alcon appoints Anup Changavalli as HeadHR, ANZ - ETHRWorld.com
Alcon (ALC) Sees Downgrade, Shares Drop 1.6% - GuruFocus
Alcon Just Got Hit With Its First Bearish Call Since August - GuruFocus
STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process - Sahm
STAAR Surgical Rebuts Investor Claims Over Alcon Deal Process - Finimize
Alcon (ALC) Faces Downgrade Amid Earnings Concerns - GuruFocus
STAAR Surgical shareholder issues statement on acquisition by Alcon - MSN
Alcon draws double downgrade at BofA on earnings growth risk - MSN
Alcon stock slips after BofA double downgrade (ALC:NYSE) - Seeking Alpha
Alcon (ALC) Involved in STAAR's Assertive Response to Merger Mis - GuruFocus
STAAR Surgical Investor Broadwood Partners Says Alcon's Proposed Acquisition Remains 'Unfair' to Shareholders - marketscreener.com
Alcon downgraded on slower Unity rollout and downside risk to earnings - Investing.com Canada
Concerns Arise Over Alcon's Proposed Acquisition of Staar Surgical (ALC) - GuruFocus
Broadwood continues opposition to STAAR’s acquisition by Alcon - Investing.com
Broadwood continues opposition to STAAR’s acquisition by Alcon By Investing.com - Investing.com South Africa
Broadwood Partners comments on STAAR Surgical board dissent on revised sale to Alcon - marketscreener.com
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon - marketscreener.com
BofA double-downgrades Alcon as growth, unity ramp fall short of expectations - Investing.com Canada
Alcon Gets Rare Sell Rating as BofA Flags Earnings Growth Risk - Bloomberg.com
Alcon stock downgraded to Underperform by BofA on dim outlook - Investing.com Australia
Alcon proposes higher bid for STAAR Surgical acquisition - Eyes On Eyecare
Death Cross: Can Alcon Inc 2U3 stock attract analyst upgradesDollar Strength & Free Daily Entry Point Trade Alerts - moha.gov.vn
STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process - Benzinga
STAAR Surgical holder Yunqi Capital still against sale to Alcon - MSN
Alcon sweetens offer for Staar, major shareholders still unimpressed - BioWorld MedTech
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical By Investing.com - Investing.com Nigeria
STAAR Surgical Acquisition by Alcon Opposed by Investor Yunqi Capital - marketscreener.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical - Investing.com
Alcon (ALC) Acquisition Proposal Faces Opposition from Major Sha - GuruFocus
Yunqi Capital comments on Staar Surgical's go-shop process and Alcon's revised offer - marketscreener.com
STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain (NASDAQ:STAA) - Seeking Alpha
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer - marketscreener.com
Is There an Opportunity in Alcon After Recent Innovation Driven Share Price Rebound? - Yahoo Finance
Alcon lifts bid for medical technology firm Staar to $1.6 billion - WHTC
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - TradingView — Track All Markets
Broadwood Partners Challenges Alcon's (ALC) Acquisition of Staar Surgical - GuruFocus
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against - Investing.com Canada
Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical - marketscreener.com
Broadwood Partners Responds to Alcon?s Increase to Acquisition Price of STAAR Surgical - marketscreener.com
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ - Stocktwits
Broadwood continues to oppose STAAR sale to Alcon despite price bump By Investing.com - Investing.com Canada
Broadwood continues to oppose STAAR sale to Alcon despite price bump - Investing.com
STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update) (STAA:NASDAQ) - Seeking Alpha
Swiss eyecare giant Alcon lifts bid for rival Staar - MSN
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):